Latest / PETRI DISH PERSPECTIVES
Episode 13: Sarepta
Send us Fan Mail
DISCLAIMER: This is a consistently changing situation. The episode was recorded approximately 4 PM EDT Monday, July 21, 2025. As of 7.40 PM EDT Monday, July 21, 2025 (Source: Sarepta), "Sarepta Therapeutics notified the U.S. FDA of its decision to voluntarily and temporarily pause all shipments of ELEVIDYS (delandistrogene moxeparvovec) for Duchenne muscular dystrophy in the United States, effective close of business Tuesday, July 22, 2025."
🎙️ When Hope Collides with Risk: Sarepta’s Gene Therapy Crisis
In this episode of Petri Dish Perspectives, Manead goes off-script to…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.